Bioasis Technologies (FRA:107) Other Current Liabilities : €0.00 Mil (As of Nov. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Bioasis Technologies Other Current Liabilities?

Bioasis Technologies's other current liabilities for the quarter that ended in Nov. 2022 was €0.00 Mil.

Bioasis Technologies's quarterly other current liabilities increased from May. 2022 (€-0.00 Mil) to Aug. 2022 (€0.00 Mil) but then from Aug. 2022 (€0.00 Mil) to Nov. 2022 (€0.00 Mil).

Bioasis Technologies's annual other current liabilities declined from Feb. 2020 (€0.00 Mil) to Feb. 2021 (€0.00 Mil) but then stayed the same from Feb. 2021 (€0.00 Mil) to Feb. 2022 (€0.00 Mil).

Bioasis Technologies Other Current Liabilities Historical Data

The historical data trend for Bioasis Technologies's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioasis Technologies Other Current Liabilities Chart

Bioasis Technologies Annual Data

Trend

Feb13

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Other Current Liabilities

Get a 7-Day Free Trial

Bioasis Technologies Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Bioasis Technologies Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Bioasis Technologies Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Bioasis Technologies's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioasis Technologies (FRA:107) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioasis Technologies Inc (FRA:107) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

157 Church Street, 19th Floor, New Haven, CT, USA, 06510

Website

https://www.bioasis.us

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

Bioasis Technologies (FRA:107) Headlines

No Headlines